Endocyte (NASDAQ:ECYT) reported Q4 2017 earnings this Morning, coming in at ($0.18) per share, missing Wall Street’s estimates of ($0.16) per Share. Revenue for the quarter came in at $0.01 million missing the streets estimates Recent Insider Trading for Endocyte (NASDAQ:ECYT)
- On 12/28/2017 Philip S Low, Insider, sold 50,511 with an average share price of $4.41 per share and the total transaction amounting to $222,753.51.
- On 12/28/2017 Philip S Low, Insider, sold 50,511 with an average share price of $4.41 per share and the total transaction amounting to $222,753.51.
- On 12/1/2017 Christopher P Leamon, VP, sold 23,231 with an average share price of $5.04 per share and the total transaction amounting to $117,084.24.
- On 11/13/2017 Philip S Low, Insider, bought 5,600 with an average share price of $4.84 per share and the total transaction amounting to $27,104.00.
- On 12/30/2016 Christopher P. Leamon, VP, sold 23,244 with an average share price of $2.55 per share and the total transaction amounting to $59,272.20.
- On 5/10/2016 Philip S Low, Insider, bought 11,375 with an average share price of $3.52 per share and the total transaction amounting to $40,040.00.
Recent Trading for Endocyte (NASDAQ:ECYT) Shares of Endocyte closed the previous trading session at 4.22 up +0.33 8.48% with 3.9000000953674316 shares trading hands.